Table 1.

Adjusted reporting odds ratio of SGLT2 inhibitors for serious skin and subcutaneous tissue disorders

	Drugs other than SGLT2 inhibitors	T2DM drugs other than SGLT2 inhibitors
Ipragliflozin	1.667 (1.415, 1.963)	2.395 (2.019, 2.840)
Dapagliflozin	0.514 (0.317, 0.835)	0.703 (0.432, 1.144)
Tofogliflozin	0.149 (0.048, 0.465)	0.200 (0.064, 0.623)
Luseogliflozin	0.624 (0.331, 1.177)	0.843 (0.447, 1.592)
Canagliflozin	0.590 (0.277, 1.257)	0.792 (0.371, 1.690)
Empagliflozin	0.293 (0.073, 1.187)	0.398 (0.098, 1.617)

The reference was drugs or T2DM drugs other than SGLT2 inhibitors.

The reporting odds ratio was adjusted by logistic regression analysis, and shown with 95% confidence limit in the parentheses.